Skip to main content

Peer Review reports

From: Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer

Original Submission
8 Jan 2019 Submitted Original manuscript
18 Jan 2019 Author responded Author comments - Chaohui Lisa Zhao
Resubmission - Version 2
18 Jan 2019 Submitted Manuscript version 2
19 Mar 2019 Reviewed Reviewer Report - Paul Henri Cottu
15 Apr 2019 Reviewed Reviewer Report - Roland Bassett
23 May 2019 Author responded Author comments - Chaohui Lisa Zhao
Resubmission - Version 3
23 May 2019 Submitted Manuscript version 3
28 May 2019 Reviewed Reviewer Report - Roland Bassett
18 Jul 2019 Reviewed Reviewer Report - Reviewer 2
13 Aug 2019 Author responded Author comments - Chaohui Lisa Zhao
Resubmission - Version 4
13 Aug 2019 Submitted Manuscript version 4
28 Aug 2019 Reviewed Reviewer Report - Reviewer 2
30 Aug 2019 Author responded Author comments - Chaohui Lisa Zhao
Resubmission - Version 5
30 Aug 2019 Submitted Manuscript version 5
3 Sep 2019 Author responded Author comments - Chaohui Lisa Zhao
Resubmission - Version 6
3 Sep 2019 Submitted Manuscript version 6
Publishing
4 Sep 2019 Editorially accepted
1 Nov 2019 Article published 10.1186/s12885-019-6134-y

You can find further information about peer review here.

Back to article page